REMED CO.,LTD. · 임원ㆍ주요주주특정증권등소유상황보고서
Report on Specified Securities Owned by Officers and Major Shareholders
6.1
리메드
20261113
Report on Specified Securities Owned by Officers and Major Shareholders
| To: Securities and Futures Commission | ||
| To: Korea Exchange | ||
| Reporting obligation date: | 2026-11-13 | |
| Report reference date: | 2026-11-17 | |
| ※ The reporting person confirms that ownership of specified securities as of the reference date is accurately stated per applicable laws and filing instructions, with no material misstatement or omission. |
| Reporting person: | 이 근 용 |
| Company Name | 리메드 | ||
| Entity type | KOSDAQ-Listed Company | Company code | 302550 |
| Total Shares Issued | 29,573,494 | ||
| Report Type | Change | Reporting person type | Individual (Domestic) | |
| Name (Entity Name) | Korean | 이 근 용 | Chinese characters (English) | 李根鎔(LEE GEUN YONG) |
| Date of Birth or Business Registration No., etc. | 680107 | |||
| Address (Head Office) [Town/District Level Only] | 경기도 수원시 영통구 봉영로 | |||
| Relationship to Issuer | Officer (Registered or Not) | Registered Officer | Position | 대표집행임원 |
| Appointment Date | 2023-11-10 | Resignation Date | - | |
| Major Shareholder | De facto controlling shareholder | |||
| Business contact and person in charge | Affiliated company | 리메드 | Department | 경영관리본부 |
| Position | 본부장 | Phone Number | 031-60** | |
| Name | 이정수 | Fax number | 031-60** | |
| Email address | **emed.kr | |||
| Report reference date | Specified Securities | Share Certificates | |||
| Number of Specified Securities (shares) | Ratio (%) | Number of Shares (shares) | Ratio (%) | ||
| Previous Report | 2018-08-21 | 8,110,000 | 32.54 | 8,110,000 | 32.54 |
| This Report | 2026-11-17 | 6,307,549 | 21.33 | 6,307,549 | 21.33 |
| Change | -1,802,451 | -11.21 | -1,802,451 | -11.21 | |
| Details of Specified Securities | |||||||||
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Participating Bonds | Exchangeable bonds | Depositary receipts | Other | Total | |
| Number of shares | Ratio (%) | ||||||||
| 6,307,549 | - | - | - | - | - | - | - | 6,307,549 | 21.33 |
| A | B | C | D | E | F | G | H | ||
| I | |||||||||
| Total Shares Issued (J) | Number of Specified Securities Other Than Shares (B+C+D+E+F+G+H=I) | Ownership ratio (%) | |
| Ownership Ratio of Specified Securities [A+I / J+I-(F+G+H)※] × 100 | Shareholding Ratio (A / J) × 100 | ||
| 29,573,494 | - | 21.33 | 21.33 |
※ Ownership ratio excludes from the denominator only exchangeable bonds exchangeable into shares and depositary receipts, derivative-linked securities, etc. with shares as underlying
| Reason for Report | Change Date* | Type of Specified Securities | Shares Owned (shares) | Acquisition/Disposal Unit Price (KRW)** | Remarks | Trading plan report date | ||
| Before Change | Change | After Change | ||||||
| Off-market sale (-) | 2026-11-13 | Common Stock | 8,110,000 | -1,802,451 | 6,307,549 | 2,774 | 메드테크1호신기술투자조합 | 2026-10-14 |
| Total | 8,110,000 | -1,802,451 | 6,307,549 | 2,774 | - | |||
* For trades on the securities market, the settlement date
** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities